Package Leaflet: Information for the User
Semonic 150mg film-coated tablets
Sertraline
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
1. What Semonic is and what it is used for
2. What you need to know before you start taking Semonic
3. How to take Semonic
4. Possible side effects
5. Storage of Semonic
6. Contents of the pack and additional information
This medicationcontains sertraline as the active ingredient. Sertraline belongs to a group of medications called Selective Serotonin Reuptake Inhibitors (SSRIs); these medications are used to treat depression and/or anxiety disorders.
This medicationmay be used to treat:
Depression is a clinical disease with symptoms such as feelings of sadness, inability to sleep well or to enjoy life as one used to.
OCD and anxiety disorders are diseases linked to anxiety, with symptoms such as being constantly preoccupied with repeated ideas (obsessions) that lead to repetitive rituals (compulsions).
PTSD is a disorder that may occur after a very emotionally traumatic experience, and has some symptoms similar to depression and anxiety. Social anxiety disorder (social phobia) is an anxiety disorder. It is characterized by intense anxiety or anguish in social situations (for example: speaking to strangers, speaking in public, eating or drinking in front of others, or worrying about behaving in a shameful manner).
Your doctor has considered this medication suitable for treating your disease.
If you are unsure why you have been prescribed this medication, you should consult your doctor.
Do not take Semonic:
Warnings and precautions:
Consult your doctor or pharmacist before starting to take this medication.
Medications are not always suitable for everyone. Before starting treatment with sertraline, inform your doctor if you have or have had any of the following circumstances:
Anxiety/Acatisia:
The use of sertraline has been associated with unpleasant anxiety and a need to move, often accompanied by an inability to sit or stand still (acatisia). This occurs more often during the first few weeks of treatment. Increasing the dose may be harmful, so if you develop these symptoms, you should contact your doctor.
Withdrawal symptoms:
Side effects related to stopping treatment (withdrawal symptoms) are common, particularly if treatment is stopped abruptly (see section 3. If you stop taking sertraline and section 4. Possible side effects). The risk of withdrawal symptoms depends on the duration of treatment, the dose, and the rate at which the dose is reduced. Generally, these symptoms are mild or moderate. However, in some patients, they can be severe. These symptoms usually occur during the first few days after stopping treatment. In general, these symptoms usually resolve on their own and usually resolve within two weeks. In some patients, they may last longer (2-3 months or more). It is recommended that when stopping treatment with sertraline, the dose be gradually reduced over a period of several weeks or even months, and you should always agree with your doctor on the best way to stop treatment.
Thoughts of suicide and worsening of your depression or anxiety disorder:
If you are depressed and/or have anxiety disorders, you may sometimes have thoughts of harming yourself or committing suicide. This may increase at the beginning of treatment with antidepressants, as all these medications take time to take effect, which is usually two weeks but can be longer.
You are more likely to experience this:
If you have thoughts of harming yourself or committing suicide at any time, contact your doctor or go to the hospital immediately.
It may be helpful for you to explain to a close family member or friend that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You can also ask them to tell you if they think your depression or anxiety is getting worse, or if they are concerned about changes in your behavior.
Children and adolescents:
Normally, sertraline should not be used to treat children and adolescents under 18 years old, except in the case of patients with obsessive-compulsive disorder (OCD). Children and adolescents under 18 years old have a higher risk of side effects such as attempts to commit suicide, thoughts of harming themselves or committing suicide (suicidal thoughts), and hostility (predominantly aggression, confrontational behavior, and irritable reaction) when treated with this class of medications. However, your doctor may decide to prescribe this medication to a patient under 18 years old if they consider it to be the most suitable for the patient. If your doctor has prescribed this medication and you are under 18 years old and want to discuss this decision, please go back to your doctor. You should inform your doctor if any of the symptoms listed above appear or worsen when you are taking this medication. At the same time, the long-term effects on safety and related to growth, maturity, and learning (cognitive development) and behavioral development of sertraline in this age group have not yet been demonstrated.
Other medications and Semonic:
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Some medications may affect how sertraline works, or sertraline itself may reduce the effectiveness of other medications you are taking at the same time.
The use of sertraline with the following medications may cause serious side effects:
Inform your doctor if you are taking the following medications:
Taking Semonic with food, drinks, and alcohol:
This medication can be taken with or without food.
Alcohol should be avoided while being treated with sertraline.
Do not take sertraline with grapefruit juice, as it may increase the levels of sertraline in your body.
Pregnancy, breastfeeding, and fertility:
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
The safety of sertraline in pregnant women has not been fully established. If you are pregnant, sertraline will only be administered to you if your doctor considers that the benefits for you outweigh any possible risk to the developing fetus.
If you take sertraline in the final stages of pregnancy, there may be an increased risk of heavy vaginal bleeding shortly after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should know that you are taking sertraline so that they can advise you.
Make sure your midwife and/or doctor know that you are taking sertraline. If you take it during pregnancy, especially in the last three months of pregnancy, medications like Semonic may increase the risk of a serious condition in newborns called persistent pulmonary hypertension (PPHN), which makes the baby breathe faster and appear blue. These symptoms usually start within the first 24 hours after birth. If this happens to your baby, contact your midwife and/or doctor immediately.
Your newborn baby may have other conditions, which usually manifest within the first 24 hours after birth. The symptoms include:
• difficulty breathing,
• blue skin or too hot or cold,
• blue lips,
• vomiting or feeding problems,
• excessive tiredness, unable to sleep, or crying a lot,
• muscle stiffness or decreased muscle tone,
• tremors, restlessness, or convulsions,
• increased reflexes,
• irritability,
• low blood sugar levels.
If your baby has any of these symptoms at birth, or you are concerned about your baby's health, consult your doctor or midwife for advice.
There is evidence that sertraline passes into breast milk. Therefore, sertraline can only be used in women while breastfeeding if your doctor considers that the benefits outweigh any possible risk to the baby.
In animal studies, some medications like sertraline have been shown to reduce the quality of sperm. Theoretically, this could affect fertility, but the impact on human fertility has not yet been determined.
Driving and operating machinery:
Psychotropic medications like sertraline can affect your ability to drive or operate machinery. Therefore, do not drive or operate heavy machinery until you know how this medication affects your ability to perform these activities.
Semonic contains lactose and sodium:
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is:
Depression and Obsessive-Compulsive Disorder:
The commonly effective dose for depression and OCD is 50 mg per day. The daily dose can be increased by 50 mg increments at intervals of at least one week, and thus for several weeks. The maximum recommended dose is 200 mg per day.
Anxiety Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder:
For anxiety disorder, social anxiety disorder, and post-traumatic stress disorder, treatment should start with a dose of 25 mg per day, and increased to 50 mg per day after one week.
The daily dose can be increased in increments of 50 mg over a period of several weeks. The maximum recommended dose is 200 mg per day.
Use in children and adolescents:
Semonic should only be used to treat children and adolescents aged 6 to 17 years with OCD.
Obsessive-Compulsive Disorder:
Children aged 6 to 12 years:The recommended starting dose is 25 mg per day. After one week, your doctor may increase the dose to 50 mg per day. The maximum dose is 200 mg per day.
Adolescents aged 13 to 17 years:The recommended starting dose is 50 mg per day. The maximum dose is 200 mg per day.
The doses of 150 and 200 mg are indicated for maintenance treatment, after 3 weeks from the start of therapy. The initial treatment begins with low doses.
If you have liver or kidney problems, inform your doctor and follow the instructions they indicate..
Administration form:
Semonic tablets can be taken with or without food.
Take your medication once a day, either in the morning or at night.
Your doctor will indicate the duration of treatment with this medication. The duration will depend on the nature of your illness and your response to treatment. It will take several weeks for your symptoms to improve. Depression treatment should continue for 6 months after improvement.
If you take more Semonic than you should:
If you accidentally take an excess ofSemonic, contact your doctor or go to the nearest hospital emergency service. Always carry the medication packaging with you, whether it contains medication or not.
You can also call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
The symptoms of overdose may include drowsiness, nausea, vomiting, rapid heart rate, tremors, agitation, dizziness, and in rare cases, unconsciousness.
If you forget to take Semonic:
Do not take a double dose to compensate for the missed doses. If you forget to take a dose, do not take it when you remember.Take the next dose when it is due.
If you interrupt treatment with Semonic:
Do not interrupt treatment withSemonicunless your doctor tells you to. Your doctor will want to gradually reduce the dose ofSemonicover several weeks before stopping it completely. If you stop treatment abruptly, you may experience adverse effects such as dizziness, numbness, sleep disturbances, agitation, anxiety, headaches, nausea, vomiting, and tremors. If you experience any of these adverse effects, or any other during the interruption of your treatment withSemonic,please inform your doctor.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
The most common side effect is nausea. Side effects depend on the dose and often disappear or decrease as treatment continues.
Inform your doctor immediately:
If you experience any of the following symptoms after taking this medicine, as these symptoms can be serious.
The following side effects were observed in clinical trials in adults and after marketing.
Very common (may affect more than 1 in 10 patients):
Insomnia, dizziness, drowsiness, headache, diarrhea, feeling unwell, dry mouth, ejaculation problems, and fatigue.
Common (may affect up to 1 in 10 patients):
Uncommon (may affect up to 1 in 100 patients):
Rare (may affect up to 1 in 1,000 patients):
Frequency not known: cannot be estimated from available data:
*Adverse effects reported after marketing.
Other adverse effects in children and adolescents
In clinical trials in children and adolescents, the adverse effects were generally similar to those reported in adults (see above). The most common adverse effects in children and adolescents were headache, insomnia, diarrhea, and nausea.
Symptoms that may appear when treatment is stopped
If you stop treatment abruptly, you may experience side effects such asdizziness, numbness, sleep disturbances, agitation or anxiety, headaches, nausea, vomiting, and tremor(see section 3. If you stop treatment with Semonic).
An increased risk of bone fractures has been observed in patients taking this type of medication.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that does not appear in this leaflet.You can also report them directly through the Spanish System for the Pharmacovigilance of Medicinal Products for Human Use:https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
The other components are: anhydrous colloidal silica, microcrystalline cellulose (E460), sodium croscarmellose, copovidone, lactose monohydrate, stearic acid, magnesium stearate (E572), hypromellose 2910, titanium dioxide (E171), macrogol (E1521).
Appearance of the product and contents of the packaging
Semonic 150 mg is presented in film-coated white or off-white, oblong, biconvex tablets (13 x 6 mm).
Semonic 150 mg is available in aluminum/PVC/PVDC blisters, in packs containing 20, 30, 50, 60, and 100 film-coated tablets.
Only some pack sizes may be marketed.
Marketing authorization holder and manufacturer responsible
Marketing authorization holder:
Neuraxpharm Spain, S.L.U.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona – Spain
Manufacturer responsible:
FERRER INTERNACIONAL, S.A.
Joan Buscallà 1-9
E-08190 Sant Cugat del Vallès
Barcelona – Spain
SVUS Pharma a.s.
Smetanovo nábrezí 1238/20a
500 02 Hradec Králové
Republic of Czech
Neuraxpharm Arzneimittel GmbH,
Elisabeth – Selbert-Str. 23
40764 Langenfeld
Germany
Neuraxpharm Pharmaceuticals, S.L.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona – Spain
This medicinal product is authorized in:
Spain | Semonic 150 mg film-coated tablets |
Portugal | Semonic 150 mg film-coated tablets |
Germany | Sertralin-neuraxpharm 150 mg Filmtabletten |
Last review date of this leaflet: December 2021
The detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.